'Ozempic vulva': A surprising side effect women aren’t talking about... until now

When it comes to the buzz around GLP-1 medications like Ozempic and Wegovy, much of the conversation has focused on weight loss, appetite suppression, and gastrointestinal side effects.

But a new wave of patient reports is bringing attention to something less discussed: changes in vulvar health.

What is 'Ozempic vulva?'

Across social media platforms, women taking these drugs are sharing experiences of 'Ozempic vulva'—a sagging of the outer labia, weakness of the vaginal muscles, and dryness. ^[]

"Loss of subcutaneous fat is global—including the mons pubis and labia majora—sometimes giving the area a deflated or ‘aged’ look. This can be due to ptosis of soft tissue, or atrophy of the fat in this area," said Justin Perron, MD, board member of the Australasian Society of Aesthetic Plastic Surgeons. ^[]

Weight loss from Ozempic can decrease muscle mass, too, which may lead to weakened pelvic muscles.

The takeaway for physicians

Counseling on potential vulvar or vaginal side effects—along with hydration strategies, gentle topical care, or referral to gynecology when appropriate—can improve adherence and patient comfort.

Open communication about less-discussed side effects signals that patient experiences matter, which may prevent unnecessary discontinuation of a therapy that could otherwise be highly beneficial.

For clinicians, this is a reminder that the scope of drug side effects often extends beyond the expected organ systems—and patient-reported outcomes can be an early warning system for issues that haven’t yet made it into formal studies.